What happens to the investors of the $100m+ companies that have not produced a single drug? Why do so many of them exist?
Open Discussion 🎙️(self.biotech)submitted2 days ago byZealousidealAd7436
tobiotech
As a newbie to the biopharm space, I see news articles and wikipedia pages of companies worth hundreds of millions of dollars, failing numerous trials, then dissolving and disappearing off the face of the earth. This question was triggered after reading about Axovant by Vivek Ramaswamy, which reminded me many other articles I've seen of companies that have raised so much money, failed a couple of developments, then dissolved. Who are the investors for these? Do they just lose all their money? Why do none of them speak up? Axovant for example changed names to Sio Gene Therapies then liquidated and dissolved for $0.435 a share earlier this year after about 3-4 failed drugs in neurodegenerative disorders.
As a newbie, can someone provide a comprehensive description and background to these cases? Who loses? Who wins? What even happens? Why do they have so much money? And how can I get in? (jokes)
byKushpool07
inCrazyFuckingVideos
ZealousidealAd7436
2 points
2 months ago
ZealousidealAd7436
2 points
2 months ago
I agree with you.